DMRA

Conviction 43HealthcareScan · Thu, Sep 24, 2026

Dragonfly doji

Damora Therapeutics, Inc. (DMRA) closed at $20.24 (-0.98%) on Sep 24, 2026. Its latest daily candle is a dragonfly doji. Price is below its 50-day. RSI(14) 26, -38.6% from its 52-week high, -20.7% year to date. Sector: Healthcare · PHARMACEUTICAL PREPARATIONS.

DMRA$20.24-0.98%

ResistanceSupportVol 14Insider sell

Vol MA14 1.07M

Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24

Damora Therapeutics, Inc.PHARMACEUTICAL PREPARATIONSwww.damoratx.com ↗

Price20.24

Change-0.98%

Gap-0.54%

Rel volume4.48×

Avg volume851.46K

Avg $ vol20.46M

SMA 2026.08

SMA 5028.65

SMA 200—

Price vs 50-29.34%

Price vs 200—

MA stack—

50/200 cross—

Supertrenddown · 25.73

RSI (14)26

MACD hist-0.70

MACD cross—

Stoch %K / %D7 / 6

ADX (14)29

+DI / −DI11 / 36

RSI divergence—

MACD divergence—

ATR %9.42%

ADR %7.53%

52w high32.99

52w low18.14

From 52w high-38.65%

Above 52w low+11.58%

New 52w highNo

SqueezeOff

Bollinger width48.29%

%B0.04

Donchian pos7.25%

Donchian high31.11

Donchian low19.39

AVWAP (52w high)26.55

vs AVWAP high-23.76%

AVWAP (52w low)25.52

vs AVWAP low-20.69%

OBV trendDown

Chaikin MF (20)-0.16

Today vs 20d4.48×

Avg vol (14d)1.07M

Avg vol (20d)851.46K

Avg $ vol (20d)20.46M

Market cap1.25B

RS Rating—

RS 3m (vs SPY)-14.81%

RS 6m (vs SPY)-36.02%

RS line new highNo

Trend template—

Technical rank8.8

1 week-11.15%

1 month-33.90%

3 months-10.32%

6 months-19.20%

1 year—

YTD-20.66%

P/E-5.95

P/B2.42

P/S—

P/FCF-180.52

EPS3.98

Div yield—

ROE-40.66%

ROA-38.60%

Debt/Eq—

Current19.73

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth-878.77%

Price target44.00

Target upside117.39%

Analyst ratingBuy

Institutional108.27%

Ent. value709.01M

Revenue—

Net income-31.17M

Gross profit—

Free cash flow-6.92M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out61.55M

Employees7

ListedThu, Oct 29, 2020

Free float217.39K

Float %0.4%

Short interest4.13M

Days to cover13.3d

Short volume62.0%

Squeeze score95 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$0.39 vs −$0.38

Last surprise-2.6% miss

Setup gradeD

Conviction43 / 100

Pattern quality—

Tech rank8.8 / 100

Group rank59 / 100

Status lane—

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirmDragonfly doji

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in DMRA

All disclosures →

No recent disclosed trades by Congress in DMRA. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in DMRA · open-market 1 sell

Insider	Side	Shares	Value	Traded	Filed
Cheng Andrew Director · Stock Option (right to buy) · 2026-08-12	Grant	30.35K	—	2026-08-12	2026-08-13
Winslow Garrett General Counsel · Common Stock · 2026-07-06	Sell	245	$7K	2026-07-06	2026-07-07
Winslow Garrett General Counsel · Common Stock · 2026-07-03	Exercise	680	—	2026-07-03	2026-07-07
Winslow Garrett General Counsel · Restricted Stock Units · 2026-07-03	Exercise	680	—	2026-07-03	2026-07-07

SEC filings

EDGAR filings in DMRA · 6 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.